Several antiviral compounds have been developed during the last decade. One such compound is ribavirin, a synthetic nucleoside structurally related to guanosine. Ribavirin therapy has been successfully used against
Ribavirin is effective to varying degrees against several RNA- and DNA-containing viruses in vitro. It has been approved for aerosol treatment of respiratory syncytial virus infections in infants. Intravenous administration has proved effective in treating Lassa fever.
Respiratory syncytial virus
Herpes simplex virus
Hepatitis B
Group A coxsackievirus
Virology